Asthmapolis, a FDA-cleared mobile health solution for asthma and COPD, has raised $5 million in a Series A round from The Social+Capital Partnership.

Asthmapolis uses a combination of smartphone applications and snap-on inhaler sensors that track when and how often patients use their inhaled medications. The geomedicine platform is available in both English and Spanish from the Apple App store and Google Play store.